Back to Search
SANJEEV KARKI, MD
MD
Internal Medicine Physician
NPI: 1528588852IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
35.148337(OH)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2015
Research & Publications (20)
1-Arylmethyl-2,3-dioxo-2,3-dihydroindole thiosemicarbazones as leads for developing cytotoxins and anticonvulsants.
PMID 18608748·J Enzyme Inhib Med Chem·2009
7-preclinical
The impact of Fc engineering on an anti-CD19 antibody: increased Fcgamma receptor affinity enhances B-cell clearing in nonhuman primates.
PMID 19109559·Blood·2009
7-preclinical
Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.
PMID 19323036·Southeast Asian J Trop Med Public Health·2009
8-other
Diagnosis of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) by fine needle aspiration cytology.
PMID 18773449·Diagn Cytopathol·2008
5-case
Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells.
PMID 18723496·Mol Cancer Ther·2008
8-other
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
PMID 18691763·Mol Immunol·2008
8-other
Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.
PMID 18653982·Jpn J Infect Dis·2008
8-other
From research to national expansion: 20 years' experience of community-based management of childhood pneumonia in Nepal.
PMID 18545735·Bull World Health Organ·2008
8-other
Longitudinal changes in zinc transport kinetics, metallothionein and zinc transporter expression in a blood-brain barrier model in response to a moderately excessive zinc environment.
PMID 18061429·J Nutr Biochem·2008
7-preclinical
The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
PMID 18498909·Clin Ther·2008
4-observational
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemia.
PMID 18829563·Cancer Res·2008
7-preclinical
Histological pattern of ovarian tumors and their age distribution.
PMID 18828427·Nepal Med Coll J·2008
8-other
A molecular immunology approach to antibody humanization and functional optimization.
PMID 17079018·Mol Immunol·2007
4-observational
Is fine needle aspiration cytology (FNAC) useful in skin adnexal masses? A study on 5 cases of pilomatixoma.
PMID 17883095·Indian J Pathol Microbiol·2007
5-case
Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
PMID 17765549·Bioorg Med Chem·2007
7-preclinical
Powder X-ray diffraction as an emerging method to structurally characterize organic solids.
PMID 17629292·Org Lett·2007
8-other
Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.
PMID 17565699·Retrovirology·2007
8-other
Design of an i.v. formulation of an unstable prodrug candidate for prostate cancer treatment: solution chemistry of N-(glutaryl-hyp-ala-ser-cyclohexylglycyl-gln-ser-leu)-doxorubicin.
PMID 16556537·Drug Dev Ind Pharm·2006
8-other
Engineered antibody Fc variants with enhanced effector function.
PMID 16537476·Proc Natl Acad Sci U S A·2006
7-preclinical
Synthesis and anticancer activity of certain mononuclear Ru (II) complexes.
PMID 17194018·J Enzyme Inhib Med Chem·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3000 MACK RD
FAIRFIELD, OH 45014 - Phone
- (513) 877-7000
Quick Facts
- NPI
- 1528588852
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile